Influence of magnesium stearate on the physicochemical and pharmacodynamic characteristics of insulin-loaded Eudragit entrapped mucoadhesive microspheres

References

• Agyilirah GA, Banker GS. (2000). Polymer for enteric coating application. In: Tarcha PJ, ed. Polymer for controlled drug delivery. : CRC press, 41–60
   Google Scholar
• Ahmed I, Goldstein B. (2006). Diabetes Mellitus. Clin Dermatol 24:237–46
   PubMed Web of Science ®Google Scholar
• Akhter DT, Nijhu RS. (2012). Diabetes mellitus: a journey of insulin. Int Curr Pharm J 1:32–42
   Google Scholar
• Apurba SA, Atqul HP, Golam K, Reza-ul J. (2009). In vitro release kinetic study of theophylline from Eudragit® RL PO matrix tablets. Dhaka Univ J Pharm Sci 8:1–6
   Google Scholar
• Attivi D. (2005). Formulation of insulin-loaded polymeric nanoparticles using response surface methodology. Drug Dev Ind Pharm 31:179–89
   PubMed Web of Science ®Google Scholar
• Beals JM, Kovach P. (1997). Insulin. In: Crommelin DJA, Sindelar RD, eds. Pharmaceutical Biotechnology, Vol. 10. : Harwood Academic Publishers, 229–39
   Google Scholar
• Builders PF, Ibekwe N, Okpako LC, et al. (2009). Preparation and characterization of mucinated cellulose microparticles for therapeutic and drug delivery purposes. Eur J Pharm Biopharm 72:34–41
   PubMed Web of Science ®Google Scholar
• Builders PF, Kunle OO, Adikwu MU. (2008a). Preparation and characterization of mucinated agarose: a mucin-agarose physical crosslink. Int J Pharm 356:174–80
   PubMed Web of Science ®Google Scholar
• Builders PF, Kunle OO, Okpaku LC, et al. (2008b). Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin. Eur J Pharm Biopharm 70:777–83
   PubMed Web of Science ®Google Scholar
• Caliceti P, Veronese EM. (1999). Improvement of the physicochemical and biopharmaceutical properties of insulin by poly (ethylene glycol) conjugation. STP Pharm Sci 9:107–13
   Google Scholar
• Cárdenas-Bailón F, Osorio-Revilla G, Gallardo-Velázquez T. (2013). Microencapsulation techniques to develop formulations of insulin for oral delivery: a review. J Microencapsul 30:409–24
   PubMed Web of Science ®Google Scholar
• Cefalu WT. (2004). Evolving strategies for insulin delivery and therapy. Drugs 64:1149–61
   PubMed Web of Science ®Google Scholar
• Chalasani KB. (2007). A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin. J Control Rel 117:421–9
   PubMed Web of Science ®Google Scholar
• Chandler SG, Thomas NW, Ilum L. (1994). Nasal absorption in the rat. III. Effect of orally lysophospholipids on insulin absorption and nasal histology. Pharm Res 11:1623–30
   PubMed Web of Science ®Google Scholar
• Chetty DJ, Chien YW. (1998). Novel methods of insulin delivery: an update. GIT Rev Ther Drug Carrier Syst 15:629–70
   PubMed Web of Science ®Google Scholar
• Chung H. (2004). Self-assembled nanocubicle as a carrier for peroral insulin delivery. Diabetologia 45:448–51
   Web of Science ®Google Scholar
• Cui F, Shi K, Zhang L. (2006). Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Rel 114:242–50
   PubMed Web of Science ®Google Scholar
• Cui FD. (2007). Preparation of insulin-loaded PLGA-Hp55 nanoparticles for oral delivery. J Pharm Sci 96:421–7
   PubMed Web of Science ®Google Scholar
• Damge C, Hillaire-Buys D, Peuche R, et al. (1995). Effect of orally administered insulin nanocapsules in normal and diabetic dogs. Diabetes Nutr Metab 8:3–9
   Google Scholar
• Damge C, Maincent P, Ubrich N. (2007). Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Rel 117:163–70
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Bergenstal RM, Cefalu WT. (2005). Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise. Diabetes Care 28:1922–8
   PubMed Web of Science ®Google Scholar
• Dorkoosh FA. (2002). Peroral delivery systems based on superporous hydrogel polymers: release characteristics for the peptide drugs buserelin, octreotide and insulin. Eur J Pharm Sci 15:433–9
   PubMed Web of Science ®Google Scholar
• Eaimtrakarn S, Ramaprasad YV, Ohno T, et al. (2002). Absorption-enhancing effect of labrasol on the intestinal absorption of insulin in rats. J Drug Target 10:255–60
   PubMed Web of Science ®Google Scholar
• Evans M, Schumm-Draeger PM, Vora J, King AB. (2011). A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations. Diabetes Obes Metab 13:677–84
   PubMed Web of Science ®Google Scholar
• Giriraj KG, Giriraj KT. (2003). Oral insulin – fact or fiction. Resonance 17:38–43
   Google Scholar
• Gowthamarajan K, Kulkarni GT. (2003). Oral insulin – fact or fiction? Possibilities of achieving oral delivery for insulin. Resonance 19:38–46
   Google Scholar
• Haznedar S, Dortunc B. (2004). Preparation and in vitro evaluation of Eudragit® microspheres containing acetazolamde. Int J Pharm 269:131–40
   PubMed Web of Science ®Google Scholar
• Heinemann L. (2002). Alternative delivery routes: inhaled insulin. Diabetes Nutr Metab Dec 156:417–22
   Google Scholar
• Heinemann L, Pfutzner A, Heise T. (2001). Alternative routes of administration as an approach to improve insulin therapy: update on dermal, oral, nasal and pulmonary insulin delivery. Curr Pharm Des Sep 7:1327–51
   PubMed Web of Science ®Google Scholar
• Hogan JE. (2008). Film–coating materials and their properties. In: Cole G, ed. Pharmaceutical coating technology. : Infoma Healthcare, 7–19
   Google Scholar
• Ichikawa H, Fukumori Y. (2007). Design of nanohydrogel-incorporated microcapsules for appropriate controlled-release of peptide drugs. Yakugaku Zasshi 127:813–23
   PubMed Web of Science ®Google Scholar
• Iwanaga KS, Ono S, Naroika K, et al. (1997). Oral delivery of insulin by using surface coating liposomes for improvement of insulin in GI tract. Int J Pharm 157:73–80
   Web of Science ®Google Scholar
• Jain D, Panda AK, Majumdar DK. (2005). Eudragit® S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech 6:1–27
   Google Scholar
• Kavimandan NJ. (2006). Synthesis and characterization of insulin-transferrin conjugates. Bioconjug Chem 17:1376–84
   PubMed Web of Science ®Google Scholar
• Kim B, Peppas NA. (2003). In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers. Int J Pharm 266:29–37
   PubMed Web of Science ®Google Scholar
• Kinesh VP, Neelam DP, Punit BP, et al. (2010). Novel approaches for oral delivery of insulin and current status of oral insulin products. Int J Pharm Sci Nanotech 3:1057–64
   Google Scholar
• Kisel MA, Kulik LN, Tsybovsky IS, et al. (2001). Liposomes with phosphatidylethanol as carrier for oral drug delivery carriers. Int J Pharm 216:105–14
   PubMed Web of Science ®Google Scholar
• Kishori LD, Nilima AT, Paraag SG. (2013). Formulation and development of tinidazole microspheres for colon targeted drug delivery system. J Pharm Res 5:158–60
   Google Scholar
• Krauland AH, Guggi D, Bernkop-Schnurch A. (2004). Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats. J Control Rel 95:547–55
   PubMed Web of Science ®Google Scholar
• Li CL, Deng YJ. (2004). Oil-based formulations for oral delivery of insulin. J Pharm Pharmacol 56:1101–7
   PubMed Web of Science ®Google Scholar
• Lin YH. (2007). Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules 8:146–52
   PubMed Web of Science ®Google Scholar
• Liu R, Huang SS, Wan YH, et al. (2006). Preparation of insulin-loaded PLA/PLGA microcapsules by a novel membrane emulsification method and its release in vitro. Colloids Surf B-Biointerfaces 51:30–8
   PubMed Web of Science ®Google Scholar
• Morishita M, Matsuzawa A, Takayama K, et al. (1998). Improving insulin enteral absorption using water-in-oil-in-water emulsion. Int J Pharm 172:189–98
   Web of Science ®Google Scholar
• Morishita M, Peppas NA. (2006). Is the oral route possible for peptide and protein drug delivery? Drug Discov Today 11:19–20
   Web of Science ®Google Scholar
• Nakamura K, Murray RJ, Joseph JI, et al. (2004). Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. J Control Rel 95:589–99
   PubMed Web of Science ®Google Scholar
• Nilkumhang S, Basit AW. (2009). The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles. Int J Pharm 377:135–41
   PubMed Web of Science ®Google Scholar
• Ofokansi KC, Adikwu MU. (2007). Formulation and evaluation of microspheres based on gelatin-mucin admixtures for the rectal delivery of cefuroxime sodium. Trop J Pharm Res 6:825–32
   Web of Science ®Google Scholar
• Ofokansi KC, Kenechukwu FC, Ogwu NN. (2014). Design of novel miconazole nitrate transdermal films based on Eudragit RS100 and HPMC hybrids: preparation, physical characterization, in vitro and ex vivo studies. Drug Deliv [Epub ahead of print]. DOI: 10.3109/10717544.2013.875604
   Google Scholar
• Owens DR. (2002). New horizons—alternative routes for insulin therapy. Nat Rev Drug Discov 1:529–40
   PubMed Web of Science ®Google Scholar
• Pamnani D. (2008). Reality check on oral insulin. Pharma Express 3:16–31
   Google Scholar
• Rosa GD, Iommeli R, Rotonda MIL, et al. (2000). Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. J Control Rel 69:283–95
   PubMed Web of Science ®Google Scholar
• Rosenstock J. (2001). Insulin therapy: optimizing control in type 1 and type 2 diabetes. Clin Cornerstone 4:50–64
   PubMedGoogle Scholar
• Sahoo J, Murthy PN, Biswal S, Manik D. (2009). Formulation of sustained release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit® RLPO or Kollidon® SR. AAPS Pharm Sci Tech 10:27–33
   PubMed Web of Science ®Google Scholar
• Sajeesh S, Sharma CP. (2006). Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int J Pharm 325:147–54
   PubMed Web of Science ®Google Scholar
• Sarciaux JM, Acar L, Sado PA. (1995). Using microemulsion formulations for oral delivery of therapeutic peptides. Int J Pharm 120:127–36
   Web of Science ®Google Scholar
• Sarmento B. (2006). Development and characterization of new insulin containing polysaccharide nanoparticles. Colloids Surf B Biointerfaces 53:193–202
   PubMed Web of Science ®Google Scholar
• Sarmento B, Martins S, Ferreira D, Souto EB. (2007). Oral insulin delivery by means of solid lipid nanoparticles. Int J Nanomed 2:743–9
   PubMed Web of Science ®Google Scholar
• Shima M, Tanaka M, Fujii T, et al. (2006). Oral administration of insulin included in fine W/O/W emulsions to rats. Food Hydrocolloids 20:523–31
   Web of Science ®Google Scholar
• Simon M. (2007). Nanosized insulin-complexes based on biodegradable amine-modified graft polyesters Poly (vinyl-3-(diethylamino)-propylcarbamate-co-(vinyl acetate)-co-(vinyl alcohol)]-graft-poly (l-lactic acid): protection against enzymatic degradation, interaction with Caco-2 cell monolayers, peptide transport and cytotoxicity. Eur J Pharm Biopharm 66:165–72
   PubMed Web of Science ®Google Scholar
• Singh MN, Hemant KSY, Ram M, Shivakumar HG. (2010). Microencapsulation: a promising technique for controlled drug delivery. Res Pharm Sci 5:65–77
   PubMedGoogle Scholar
• Singh S, Patel D, Patel NR, et al. (2010b). Insulin oral delivery may be possible. Int J Pharm Prof Res 1:46–51
   Google Scholar
• Tiyaboonchai W. (2003). Insulin containing polyethyleni-mine-dextran sulfate nanoparticles. Int J Pharm 255:139–51
   PubMed Web of Science ®Google Scholar
• Toorisaka E, Hashida M, Kamiya N, et al. (2005). An enteric-coated dry emulsion formulation for oral insulin delivery. J Control Rel 107:91–6
   PubMed Web of Science ®Google Scholar
• Tozaki H. (2001). Enhanced absorption of insulin and (Asu (1, 7)) eel-calcitonin using novel azopolymer-coated pellets for colon-specific drug delivery. J Pharm Sci 90:89–97
   PubMed Web of Science ®Google Scholar
• Tozaki H, Komike J, Tada C, et al. (1997). Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from rats. J Pharm Sci 86:1016–21
   PubMed Web of Science ®Google Scholar
• Tuesca A, Lowman A. (2006). The oral delivery of insulin using protein conjugates in complexation hydrogels. Poster presentation, Biomaterials and drug delivery laboratory, Drexel University, Philadelphia, Pennsylvania, USA
   Google Scholar
• Whitehead K, Shen Z, Mitragotri S. (2004). Oral delivery of macromolecules using intestinal patches: applications for insulin delivery. J Control Rel 98:37–45
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Taniguchi T, Rikyuu K, et al. (1994). Effect of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm Res 11:1496–500
   PubMed Web of Science ®Google Scholar
• Yüksel N, Baykara T. (1997). Preparation of polymeric microspheres by the solvent evaporation method using sucrose stearate as a droplet stabilizer. J Microencapsul 14:725–33
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu X, Meng L, et al. (2012b). Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. Int J Pharm 436:341–50
   PubMed Web of Science ®Google Scholar
• Zhao N, Augsburger LL. (2005). The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS Pharm Sci Tech 6:E120–6
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wei W, Lv P, et al. (2011). Preparation and evaluation of alginate–chitosan microspheres for oral delivery of insulin. Eur J Pharm Biopharm 77:11–9
   PubMed Web of Science ®Google Scholar